These 23 serotypes can protect against approximately 50-60% of the strains that cause pneumococcal disease in adults
As a member of the class B GPCR family, GCGR is involved in various physiological processes and is a valuable drug target for a range of diseases, including diabetes, metabolic syndrome, osteoporosis, migraine,depression, and anxiety[2], with a particularly important role in the treatment of type 2 diabetes
The next decade of obesity drug development is a tuning exercise, not a discovery exercise, and the IP positions that will matter most are the narrow molecular claims that lock in specific ratios
p.) oder Reserpin (ein Katecholamin-Vesikelentleerungsmittel) (5,0 mg/kg b
The pharmacist is responsible for the quality and accuracy of each compound
Experts will explore strategic trial frameworks for natural health products and adjunctive supports, share insights on Canadian and U.S